7.25
Precedente Chiudi:
$7.34
Aprire:
$7.37
Volume 24 ore:
394.31K
Relative Volume:
0.26
Capitalizzazione di mercato:
$224.76M
Reddito:
-
Utile/perdita netta:
$-29.25M
Rapporto P/E:
-6.113
EPS:
-1.186
Flusso di cassa netto:
$-22.80M
1 W Prestazione:
-4.10%
1M Prestazione:
-14.20%
6M Prestazione:
+107.14%
1 anno Prestazione:
+151.74%
Sagimet Biosciences Inc Stock (SGMT) Company Profile
Nome
Sagimet Biosciences Inc
Settore
Industria
Telefono
(650) 561-8600
Indirizzo
155 BOVET RD., SUITE 303, SAN MATEO
Confronta SGMT con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
![]()
SGMT
Sagimet Biosciences Inc
|
7.25 | 239.36M | 0 | -29.25M | -22.80M | -1.186 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
![]()
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
![]()
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Sagimet Biosciences Inc Stock (SGMT) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2025-08-11 | Iniziato | Wedbush | Outperform |
2025-08-07 | Ripresa | H.C. Wainwright | Buy |
2025-07-24 | Iniziato | Canaccord Genuity | Buy |
2024-12-06 | Iniziato | Oppenheimer | Outperform |
2024-11-12 | Iniziato | UBS | Buy |
2024-06-28 | Downgrade | Goldman | Buy → Neutral |
2024-05-02 | Iniziato | H.C. Wainwright | Buy |
2024-03-25 | Iniziato | Leerink Partners | Outperform |
2023-08-08 | Iniziato | Goldman | Buy |
2023-08-08 | Iniziato | JMP Securities | Mkt Outperform |
2023-08-08 | Iniziato | Piper Sandler | Overweight |
2023-08-08 | Iniziato | TD Cowen | Outperform |
Mostra tutto
Sagimet Biosciences Inc Borsa (SGMT) Ultime notizie
What is the Moat Score of Sagimet Biosciences Inc.2025 AllTime Highs & Expert Verified Movement Alerts - khodrobank.com
Applying sector rotation models to Sagimet Biosciences Inc.July 2025 PostEarnings & Pattern Based Trade Signal System - Newser
Is Sagimet Biosciences Inc. gaining market shareTrend Reversal & Free High Accuracy Swing Entry Alerts - khodrobank.com
How to build a dashboard for Sagimet Biosciences Inc. stockMarket Sentiment Report & Technical Pattern Alert System - Newser
How high can Sagimet Biosciences Inc. stock go2025 Market Overview & Daily Risk Controlled Trade Plans - Newser
Is Sagimet Biosciences Inc. stock a buy or sellMarket Risk Analysis & Reliable Price Breakout Alerts - khodrobank.com
Can Sagimet Biosciences Inc. deliver consistent dividendsJuly 2025 Market Mood & Reliable Intraday Trade Plans - khodrobank.com
Is Sagimet Biosciences Inc. meeting your algorithmic filter criteriaLong Setup & Real-Time Chart Breakout Alerts - Newser
Earnings visualization tools for Sagimet Biosciences Inc.Options Play & Safe Capital Investment Plans - Newser
Can volume confirm reversal in Sagimet Biosciences Inc.Forecast Cut & High Accuracy Trade Alerts - Newser
Is Sagimet Biosciences Inc. stock a good pick for beginnersJuly 2025 Analyst Calls & Real-Time Volume Analysis Alerts - khodrobank.com
Real time social sentiment graph for Sagimet Biosciences Inc.2025 Breakouts & Breakdowns & AI Powered Market Entry Strategies - Newser
Sagimet Biosciences Inc. stock momentum explained2025 Investor Takeaways & Free Fast Entry Momentum Trade Alerts - Newser
Is Sagimet Biosciences Inc. stock bottoming outWatch List & Daily Market Momentum Tracking - Newser
How high can Sagimet Biosciences Inc. stock price go in 2025Bear Alert & Low Drawdown Momentum Trade Ideas - Newser
How to monitor Sagimet Biosciences Inc. with trend dashboardsAnalyst Upgrade & Breakout Confirmation Alerts - Newser
Sagimet Biosciences Inc.’s volatility index tracking explainedTreasury Yields & AI Forecasted Stock Moves - Newser
Using data filters to optimize entry into Sagimet Biosciences Inc.Quarterly Growth Report & Free Safe Capital Growth Stock Tips - Newser
Tools to monitor Sagimet Biosciences Inc. recovery probabilityWeekly Trade Report & Community Consensus Picks - Newser
Momentum Screeners Rank Sagimet Biosciences Inc. in Top 5 TodayJuly 2025 Pullbacks & Advanced Technical Analysis Signals - beatles.ru
Sagimet Biosciences: Strong Pipeline Progress, Funding Overhang Keeps Stock at Hold - AInvest
Sagimet Biosciences: Strong Denifanstat Pipeline Progress, Funding Overhang Keeps Stock At Hold - Seeking Alpha
Sagimet Biosciences Inc. recovery potential after sell offJuly 2025 Sector Moves & Weekly Market Pulse Updates - Newser
How to use a screener to detect Sagimet Biosciences Inc. breakoutsLong Setup & AI Enhanced Market Trend Forecasts - Newser
Is Sagimet Biosciences Inc. building a consolidation baseWeekly Profit Recap & Fast Moving Stock Trade Plans - Newser
Sector ETF performance correlation with Sagimet Biosciences Inc.Buy Signal & Technical Pattern Based Signals - Newser
Will Sagimet Biosciences Inc. Reverse From Oversold ConditionsSwing Trade & Safe Entry Zone Identification - beatles.ru
Custom watchlist performance reports with Sagimet Biosciences Inc.2025 Short Interest & Real-Time Chart Pattern Alerts - Newser
Sagimet Biosciences Inc Azioni (SGMT) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Sagimet Biosciences Inc Azioni (SGMT) insider trading
Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
---|---|---|---|---|---|---|---|
Martins Eduardo Bruno | Chief Medical Officer |
Jul 21 '25 |
Sale |
9.13 |
8,277 |
75,607 |
106,936 |
Rozek Elizabeth | General Counsel and CCO |
Jul 21 '25 |
Sale |
9.13 |
10,780 |
98,471 |
183,726 |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):